nodes	percent_of_prediction	percent_of_DWPC	metapath
Methamphetamine—MAOB—Dopamine metabolism—TYR—vitiligo	0.314	0.324	CbGpPWpGaD
Methamphetamine—MAOA—Dopamine metabolism—TYR—vitiligo	0.197	0.203	CbGpPWpGaD
Methamphetamine—TAAR1—G alpha (s) signalling events—MC1R—vitiligo	0.0431	0.0445	CbGpPWpGaD
Methamphetamine—MAOB—Tryptophan metabolism—CAT—vitiligo	0.0221	0.0228	CbGpPWpGaD
Methamphetamine—SLC6A3—Parkinsons Disease Pathway—CASP7—vitiligo	0.0208	0.0214	CbGpPWpGaD
Methamphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—MC1R—vitiligo	0.0205	0.0212	CbGpPWpGaD
Methamphetamine—MAOA—Oxidative Stress—CAT—vitiligo	0.0195	0.0202	CbGpPWpGaD
Methamphetamine—TAAR1—GPCR ligand binding—MC1R—vitiligo	0.0156	0.0162	CbGpPWpGaD
Methamphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—CCR6—vitiligo	0.0153	0.0158	CbGpPWpGaD
Methamphetamine—TAAR1—neck—vitiligo	0.013	0.415	CbGeAlD
Methamphetamine—TAAR1—GPCR ligand binding—CCR6—vitiligo	0.0117	0.0121	CbGpPWpGaD
Methamphetamine—MAOB—Biological oxidations—GSTT1—vitiligo	0.0114	0.0118	CbGpPWpGaD
Methamphetamine—TAAR1—GPCR downstream signaling—MC1R—vitiligo	0.00884	0.00913	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling by GPCR—MC1R—vitiligo	0.00803	0.00829	CbGpPWpGaD
Methamphetamine—MAOB—Biological oxidations—GSTM1—vitiligo	0.00727	0.00751	CbGpPWpGaD
Methamphetamine—MAOA—Biological oxidations—GSTT1—vitiligo	0.00716	0.0074	CbGpPWpGaD
Methamphetamine—TAAR1—GPCR downstream signaling—CCR6—vitiligo	0.0066	0.00682	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCRs, Class A Rhodopsin-like—MC1R—vitiligo	0.0066	0.00681	CbGpPWpGaD
Methamphetamine—SLC6A4—NRF2 pathway—GSTM1—vitiligo	0.00635	0.00655	CbGpPWpGaD
Methamphetamine—TAAR1—thyroid gland—vitiligo	0.00618	0.198	CbGeAlD
Methamphetamine—ADRA2C—GPCRs, Class A Rhodopsin-like—MC1R—vitiligo	0.00616	0.00636	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling by GPCR—CCR6—vitiligo	0.006	0.00619	CbGpPWpGaD
Methamphetamine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—MC1R—vitiligo	0.00565	0.00584	CbGpPWpGaD
Methamphetamine—SLC6A2—NRF2 pathway—GSTM1—vitiligo	0.00546	0.00563	CbGpPWpGaD
Methamphetamine—ADRA2B—G alpha (i) signalling events—CCR6—vitiligo	0.00531	0.00548	CbGpPWpGaD
Methamphetamine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—MC1R—vitiligo	0.00528	0.00545	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCRs, Class A Rhodopsin-like—MC1R—vitiligo	0.00501	0.00517	CbGpPWpGaD
Methamphetamine—ADRA2C—G alpha (i) signalling events—CCR6—vitiligo	0.00496	0.00512	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCRs, Class A Rhodopsin-like—CCR6—vitiligo	0.00493	0.00509	CbGpPWpGaD
Methamphetamine—SLC6A3—NRF2 pathway—GSTM1—vitiligo	0.00484	0.00499	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—MC1R—vitiligo	0.00474	0.0049	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCRs, Class A Rhodopsin-like—CCR6—vitiligo	0.0046	0.00475	CbGpPWpGaD
Methamphetamine—MAOA—Biological oxidations—GSTM1—vitiligo	0.00456	0.00471	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR ligand binding—MC1R—vitiligo	0.00431	0.00444	CbGpPWpGaD
Methamphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—MC1R—vitiligo	0.00429	0.00443	CbGpPWpGaD
Methamphetamine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CCR6—vitiligo	0.00422	0.00436	CbGpPWpGaD
Methamphetamine—ADRA2A—G alpha (i) signalling events—CCR6—vitiligo	0.00403	0.00416	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR ligand binding—MC1R—vitiligo	0.00402	0.00415	CbGpPWpGaD
Methamphetamine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CCR6—vitiligo	0.00394	0.00407	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCRs, Class A Rhodopsin-like—CCR6—vitiligo	0.00374	0.00386	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—CCR6—vitiligo	0.00354	0.00366	CbGpPWpGaD
Methamphetamine—TAAR1—GPCR downstream signaling—IL2RA—vitiligo	0.00347	0.00358	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—SH2B3—vitiligo	0.00336	0.00347	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—GZMB—vitiligo	0.00334	0.00345	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR ligand binding—MC1R—vitiligo	0.00327	0.00337	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR ligand binding—CCR6—vitiligo	0.00322	0.00332	CbGpPWpGaD
Methamphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCR6—vitiligo	0.0032	0.00331	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling by GPCR—IL2RA—vitiligo	0.00315	0.00325	CbGpPWpGaD
Methamphetamine—CYP2D6—Biological oxidations—GSTT1—vitiligo	0.00312	0.00322	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR ligand binding—CCR6—vitiligo	0.003	0.0031	CbGpPWpGaD
Methamphetamine—ADRA2B—Platelet activation, signaling and aggregation—IL2RA—vitiligo	0.00293	0.00303	CbGpPWpGaD
Methamphetamine—ADRA2C—Platelet activation, signaling and aggregation—IL2RA—vitiligo	0.00274	0.00283	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—SH2B3—vitiligo	0.00273	0.00281	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—SH2B3—vitiligo	0.00255	0.00263	CbGpPWpGaD
Methamphetamine—MAOA—neck—vitiligo	0.00248	0.0793	CbGeAlD
Methamphetamine—ADRA2A—GPCR ligand binding—CCR6—vitiligo	0.00244	0.00252	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—MC1R—vitiligo	0.00243	0.00251	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—MC1R—vitiligo	0.00227	0.00235	CbGpPWpGaD
Methamphetamine—ADRA2A—Platelet activation, signaling and aggregation—IL2RA—vitiligo	0.00222	0.0023	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—CD44—vitiligo	0.00221	0.00228	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—MC1R—vitiligo	0.00221	0.00228	CbGpPWpGaD
Methamphetamine—SLC18A2—thyroid gland—vitiligo	0.0021	0.0671	CbGeAlD
Methamphetamine—ADRA2A—Hemostasis—SH2B3—vitiligo	0.00207	0.00214	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—CD44—vitiligo	0.00207	0.00213	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—MC1R—vitiligo	0.00206	0.00213	CbGpPWpGaD
Methamphetamine—CYP2D6—Biological oxidations—GSTM1—vitiligo	0.00199	0.00205	CbGpPWpGaD
Methamphetamine—CYP2D6—Metapathway biotransformation—GSTM1—vitiligo	0.00196	0.00202	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—GSTT1—vitiligo	0.00195	0.00202	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—IL2RA—vitiligo	0.00186	0.00192	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—MC1R—vitiligo	0.00185	0.00191	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—CCR6—vitiligo	0.00182	0.00188	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—CCR6—vitiligo	0.0017	0.00175	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—CD44—vitiligo	0.00168	0.00173	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—MC1R—vitiligo	0.00168	0.00173	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—GSTT1—vitiligo	0.00165	0.00171	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—CCR6—vitiligo	0.00165	0.0017	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—CD44—vitiligo	0.00162	0.00168	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—CD80—vitiligo	0.00155	0.0016	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—CCR6—vitiligo	0.00154	0.00159	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—IL2RA—vitiligo	0.00151	0.00156	CbGpPWpGaD
Methamphetamine—SLC22A3—thyroid gland—vitiligo	0.0015	0.0478	CbGeAlD
Methamphetamine—SLC22A5—skin of body—vitiligo	0.00148	0.0473	CbGeAlD
Methamphetamine—ADRA2C—Hemostasis—IL2RA—vitiligo	0.00141	0.00146	CbGpPWpGaD
Methamphetamine—MAOB—thyroid gland—vitiligo	0.00138	0.0442	CbGeAlD
Methamphetamine—ADRA2A—GPCR downstream signaling—CCR6—vitiligo	0.00138	0.00142	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—CD44—vitiligo	0.00137	0.00142	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—CAT—vitiligo	0.00132	0.00136	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—MC1R—vitiligo	0.00131	0.00135	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—CCR6—vitiligo	0.00125	0.00129	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—GSTM1—vitiligo	0.00124	0.00128	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—GSTT1—vitiligo	0.00123	0.00126	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—MC1R—vitiligo	0.00122	0.00126	CbGpPWpGaD
Methamphetamine—MAOA—thyroid gland—vitiligo	0.00118	0.0378	CbGeAlD
Methamphetamine—ADRA2A—Hemostasis—IL2RA—vitiligo	0.00115	0.00118	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—CAT—vitiligo	0.00111	0.00115	CbGpPWpGaD
Methamphetamine—SLC22A5—thyroid gland—vitiligo	0.00109	0.0348	CbGeAlD
Methamphetamine—SLC22A3—Metabolism—GSTM1—vitiligo	0.00105	0.00109	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—CD44—vitiligo	0.00102	0.00105	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—GSTT1—vitiligo	0.00101	0.00104	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—MC1R—vitiligo	0.00099	0.00102	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CCR6—vitiligo	0.000975	0.00101	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—IL2RA—vitiligo	0.000955	0.000986	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—SH2B3—vitiligo	0.000924	0.000954	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—GZMB—vitiligo	0.000919	0.000948	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CCR6—vitiligo	0.000911	0.00094	CbGpPWpGaD
Methamphetamine—ADRA2A—thyroid gland—vitiligo	0.000906	0.029	CbGeAlD
Methamphetamine—ADRA2C—GPCR downstream signaling—IL2RA—vitiligo	0.000892	0.000921	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—IL2RA—vitiligo	0.000867	0.000895	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—SH2B3—vitiligo	0.000863	0.000891	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—GZMB—vitiligo	0.000858	0.000886	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—CD44—vitiligo	0.000838	0.000865	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—CAT—vitiligo	0.000826	0.000853	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—GSTT1—vitiligo	0.000819	0.000845	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—IL2RA—vitiligo	0.00081	0.000836	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—GSTM1—vitiligo	0.00078	0.000806	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CCR6—vitiligo	0.00074	0.000764	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—IL2RA—vitiligo	0.000724	0.000748	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—SH2B3—vitiligo	0.000701	0.000724	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—GZMB—vitiligo	0.000697	0.000719	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—CD44—vitiligo	0.00068	0.000702	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—CAT—vitiligo	0.00068	0.000702	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—IL2RA—vitiligo	0.000658	0.000679	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—GSTM1—vitiligo	0.000642	0.000663	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—CAT—vitiligo	0.000552	0.00057	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—GSTT1—vitiligo	0.000533	0.000551	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—GSTM1—vitiligo	0.000521	0.000538	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—IL2RA—vitiligo	0.000512	0.000529	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—IL2RA—vitiligo	0.000478	0.000494	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—CD44—vitiligo	0.000443	0.000458	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CD80—vitiligo	0.000427	0.000441	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CD80—vitiligo	0.000399	0.000412	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IL2RA—vitiligo	0.000389	0.000401	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—CAT—vitiligo	0.00036	0.000371	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—GSTM1—vitiligo	0.00034	0.000351	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CD80—vitiligo	0.000324	0.000335	CbGpPWpGaD
